Showing results (71-80 of 132) with videos related to
Sort By:
Pageof 14
American Heart Journal|July 12, 2011
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT)Judith E Mitchell, S William Tam, Kamini Trivedi, et al.Journal of Cardiac Failure|November 11, 2008
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure TrialJalal K Ghali, S William Tam, Michael L Sabolinski, et al.European Journal of Heart Failure|January 3, 2006
Signs and symptoms in chronic heart failure: relevance of clinical trial results to point of care-data from Val-HeFTMaylene Wong, Lidia Staszewsky, Elisa Carretta, et al.American Journal of Hypertension|August 4, 2004
Determinants of radial artery pulse wave analysis in asymptomatic individualsDaniel A Duprez, Daniel R Kaiser, Wayne Whitwam, et al.Lancet (London, England)|July 28, 2004
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trialInder Anand, John McMurray, Jay N Cohn, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 16, 2004
Antihypertensive utility of perindopril in a large, general practice-based clinical trialStevo Julius, Jay N Cohn, Joel Neutel, et al.American Heart Journal|October 18, 2003
Screening for early detection of cardiovascular disease in asymptomatic individualsJay N Cohn, Lynn Hoke, Wayne Whitwam, et al.European Journal of Heart Failure|November 11, 2003
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)Jay N Cohn, Marc A Pfeffer, Jean Rouleau, et al.Journal of the American College of Cardiology|June 3, 2004
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic dataMaylene Wong, Lidia Staszewsky, Roberto Latini, et al.European Journal of Heart Failure|November 24, 2004
Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFTHenry Krum, Peter Carson, Csaba Farsang, et al.Pageof 14